Featured Content |Content Library
An online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people who should undergo testing for inherited genetic changes that raise the risk of developing certain cancers, a new study shows.
Until recently, when adults with acute lymphocytic leukemia (ALL) weren't cured or put into prolonged remission by standard chemotherapy, "there really was no good treatment option," says Marlise Luskin, MD, MSCE, a leukemia specialist ...
Today, President Joe Biden announced that he is appointing Monica Bertagnolli, MD, surgical oncologist in the Dana-Farber Brigham Cancer Center and at Brigham and Women’s Hospital and member of the Gastrointestinal and Sarcoma Treatment ...
This conference will educate attendees on state-of-the-art approaches to managing individuals with known or suspected Lynch syndrome, a common, inherited form of cancer predisposition.
Receive Dana-Farber's e-newsletter, Momentum, to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.
- GU Oncology Conference Highlights: ASCO 2022
- Breast Cancer Treatment
- Research News Updates
- Faculty Updates
- Identification & Management
of Lynch Syndrome in Clinical Practice
- Stem Cell Transplant and Cellular Therapies Symposium: Navigating the “New Normal"
- Transatlantic Exchanges in Immuno-Oncology CME
- Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management
- Hematologic Malignancies CME - 2021
- Master Class for Oncologists
- Cancer Survivorship: Optimizing Care and Outcomes